BDULF (BDULF) Stock Price & Analysis
BDULF (BDULF) fell 0.87% to USD 0.56 as of June 10, 2026 at 02:23 UTC, according to Nexqual real-time market data.
BDULF last closed at USD 0.56; the session ranged USD 0.56–0.56 on volume of 2,423 shares. Market capitalization is $9.57B, with a 52-week range of USD 0.56–0.69 (PNK). Source: Nexqual, June 10, 2026 at 02:23 UTC.
Key Statistics (as of June 10, 2026 at 02:23 UTC)
| Price | USD 0.56 |
|---|---|
| Change | ▼ 0.87% (down) |
| Previous Close | USD 0.56 |
| Open | USD 0.56 |
| Day Range | USD 0.56 – 0.56 |
| 52-Week Range | USD 0.56 – 0.69 |
| Volume | 2,423 shares |
| Market Cap | $9.57B |
| Exchange | PNK |
Technical Analysis (BDULF)
Nexqual's technical model rates BDULF "SELL" based on 2 bullish and 5 bearish signals across 123 daily candles, as of June 10, 2026 at 02:23 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 0 (oversold) |
| vs SMA50 | Below (USD 0.64) |
| MACD | -0.03 (negative) |
Analyst Ratings (BDULF)
Wall Street analysts rate BDULF "None", per Nexqual as of June 10, 2026 at 02:23 UTC.
| Consensus Rating | None |
|---|
Earnings (BDULF)
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Financials & Fundamentals (BDULF)
| Total Revenue | $113.31B |
|---|---|
| Revenue Growth (YoY) | +0.40% |
| Gross Margin | +36.69% |
| Operating Margin | +18.27% |
| Profit Margin | +13.73% |
| ROE | +14.42% |
| Debt / Equity | 12.27 |
| Current Ratio | 1.16 |
| Total Cash | $7.39B |
| Total Debt | $14.02B |
| Free Cash Flow | $7.23B |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Financial Health Score (BDULF)
Nexqual rates BDULF's overall financial health "Solid" across five dimensions, as of June 10, 2026 at 02:23 UTC.
| Growth | Mixed — Revenue +3.4% YoY (annual), slow |
|---|---|
| Profitability | Solid — Gross margin 37%, operating 18% |
| Balance Sheet | Strong — $7.39B cash vs $14.0B debt |
| Cash Flow | Solid — FCF $7.23B, 6% margin |
| Efficiency | Mixed — ROE 14%, ROA 7.8% |
Ownership (BDULF)
| Insider Ownership | +0.00% |
|---|---|
| Institutional Ownership | +10.13% |
| Shares Outstanding | 0 |
| Float | 12.84B |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Leadership (BDULF)
BDULF is led by Poramaporn Prasarttong-Osoth (age 54), President, Senior CEO of Group 1 & Authorized Director, per Nexqual as of June 10, 2026 at 02:23 UTC.
| President, Senior CEO of Group 1 & Authorized Director | Poramaporn Prasarttong-Osoth (age 54) |
|---|---|
| Executive Vice Chairman | Chuladej Yossundharakul (age 92) |
| Senior EVP, CFO & Authorized Director | Narumol Noi-Am (age 67) |
| COO & Executive Director | Chairat Panthuraamphorn (age 70) |
| Chief Administration Officer & Authorized Director | Sripop Sarasas (age 68) |
Major Backers & Investors (BDULF)
Notable institutional backers of BDULF include -Price (T.Rowe) Emerging Markets Discovery Stock Trust, FINANCIAL INVESTORS TRUST-Seafarer Overseas Growth and Income Fund, T. Rowe Price, according to Nexqual as of June 10, 2026 at 02:23 UTC.
Active Investors
| Investor | Stake |
|---|---|
| -Price (T.Rowe) Emerging Markets Discovery Stock Trust | 0.35% |
| FINANCIAL INVESTORS TRUST-Seafarer Overseas Growth and Income Fund | 0.31% |
| T. Rowe Price | 0.3% |
| ALLSPRING FUNDS TRUST-Allspring Emerging Markets Equity Fund | 0.21% |
| AIM Investment Fd.s -Invesco Developing Markets Fd. | 0.16% |
| AIM Intl Mutual Fd.s -Invesco EQV Intl Eqy. Fd. | 0.13% |
Index Funds (Passive)
| Fund | Stake |
|---|---|
| Vanguard Group | 2.02% |
Source: Nexqual, June 10, 2026 at 02:23 UTC.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| BDUUF | BANGKOK DUSIT MEDICAL SERVICES | USD 0.6 | ▼ 6.25% |
| ALPMF | Astellas Pharma, Inc. | USD 14.26 | ▲ 0.42% |
| AVIFY | Advanced Info Service Public Co | USD 10.4 | ▲ 2.77% |
| CRBJF | China Resources Land Ltd. | USD 3.8 | ▲ 0% |
| AIRYY | Air China, Ltd. | USD 11.55 | ▲ 0.09% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: June 10, 2026 at 02:23 UTC. This page is informational and not investment advice.